GCP
BIOA

GSA Capital Partners’s BioAge Labs BIOA Stock Holding History

GSA Capital Partners’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-30,723
Closed -$181K – 2157
2025
Q3 		$181K Buy
+30,723
New +$144K 0.02% 1451
2025
Q1 		– Sell
-12,146
Closed -$70K – 2147
2024
Q4 		$70K Buy
+12,146
New +$209K 0.01% 1522

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

GSA Capital Partners's BIOA Position: Q4 2025 in Review

GSA Capital Partners sold out of BioAge Labs (BIOA) in Q4 2025, closing a stake of 30,723 shares — an estimated $181K sold.

GSA Capital Partners first reported a position in BIOA in Q4 2024 and held it in 2 quarters. The position peaked at $181K in Q3 2025. 114 funds tracked by Wall St. Rank hold BIOA as of Q4 2025.

  • GSA Capital Partners reported no remaining BioAge Labs position as of Q4 2025 after selling out during the quarter.
  • GSA Capital Partners sold 30,723 BioAge Labs shares in Q4 2025, an estimated $181K.
  • GSA Capital Partners first reported a position in BioAge Labs in Q4 2024 and held it in 2 quarters.
  • GSA Capital Partners's BioAge Labs position peaked at $181K in Q3 2025.
  • 114 funds tracked by Wall St. Rank held BioAge Labs as of Q4 2025.

Based on GSA Capital Partners's 13F filing for Q4 2025, filed 6 Feb 2026.